Last reviewed · How we verify
NCT04823455: ALLO-OMERO2020
Results Following Fresh-frozen Humeral Head Osteochondral Allograft Reconstruction for Reverse Hill-Sachs Lesion
NA trial testing fresh-frozen humeral head osteochondral allograft reconstruction for reverse Hill-Sachs lesion in Shoulder Dislocation Closed Traumatic in 12 participants. Completed in 30 April 2021.
5 August 2020
Quick facts
| Lead sponsor | Istituto Ortopedico Rizzoli |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 12 |
| Start date | 5 June 2020 |
| Primary completion | 5 August 2020 |
| Estimated completion | 30 April 2021 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- fresh-frozen humeral head osteochondral allograft reconstruction for reverse Hill-Sachs lesion
Conditions studied
- Shoulder Dislocation Closed Traumatic — all drugs for Shoulder Dislocation Closed Traumatic →
Sponsor
Istituto Ortopedico Rizzoli — full company profile →
Who can join
Adults 18 to 90, any sex, with Shoulder Dislocation Closed Traumatic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Locked posterior glenohumeral dislocations with a reverse Hill-Sachs impaction fracture involving less than 30% of the humeral head are most frequently treated with lesser tuberosity transfer into the defect, whereas those involving more than 50% undergo humeral head arthroplasty. Reconstruction of the defect with segmental femoral osteochondral allografts has been proposed to treat patients between these two ranges, but the medium-/long-term outcomes of this joint-preserving procedure are controversial.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Mid-Term outcomes following fresh-frozen humeral head osteochondral allograft reconstruction for reverse Hill Sachs lesion: a case series.
Marcheggiani Muccioli GM, Rinaldi VG, Lullini G, Ritali A, et al · · 2021 · cited 14× · PMID 34496807 · DOI 10.1186/s12891-021-04657-z
Verify or expand the search:
- PubMed search for NCT04823455
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Istituto Ortopedico Rizzoli trials
Trials by the same sponsor.
- NCT07590882 — Evaluation of Return to Sports Activity After Periacetabular Osteotomy: An Observational Study · enrolling by invitation
- NCT07021222 — Multifactorial Strategies for the Prevention of the Risks of Ulceration in Patients Affected by Diabetic Foot (DARE-DiaF · NA · recruiting
- NCT07360964 — Clear Cell Chondrosarcoma in Italy · NA · active not recruiting
- NCT07140367 — "Transarterial Microembolization (TAME) in Inflammatory Knee Pathology" · recruiting
- NCT07102875 — Ready to Sail 2: A Pilot Study of Sail-Assisted Telerehabilitation in Rare Skeletal Diseases · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04823455 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istituto Ortopedico Rizzoli
- Last refreshed: 23 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04823455.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing